Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51851-51900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06313983
A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
PHASE3Recruiting
339 participants
Started: Jan 8, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05562375
Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders
NARecruiting
73 participants
Started: Jan 8, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05134857
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
PHASE2Recruiting
205 participants
Started: Jan 7, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06330441
Pancreatic Cancer Screening in a Population at High Risk
NARecruiting
700 participants
Started: Jan 7, 2022 · Completed: Jan 6, 2028
3 conditions2 sponsors1 location
NCT04886895
Motor Training for Infants With Cerebral Palsy
NARecruiting
35 participants
Started: Jan 7, 2022 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT04903015
Cerebral and Cognitive Impact of Professional Soccer Practice
NARecruiting
80 participants
Started: Jan 7, 2022 · Completed: Feb 7, 2026
1 condition1 sponsor1 location
NCT06392139
Specialized Healthcare Service for BPD Patients: Athens Trial
NARecruiting
156 participants
Started: Jan 7, 2022 · Completed: Jun 30, 2026
1 condition5 sponsors3 locations
NCT05610436
Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors
N/ARecruiting
500 participants
Started: Jan 7, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06338306
Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes
N/ARecruiting
25 participants
Started: Jan 7, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT07011979
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
N/ARecruiting
500 participants
Started: Jan 7, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05740488
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
NARecruiting
30 participants
Started: Jan 7, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05123807
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
PHASE2Recruiting
30 participants
Started: Jan 7, 2022 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT04840264
Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction
PHASE2Recruiting
79 participants
Started: Jan 7, 2022 · Completed: Jun 30, 2027
3 conditions1 sponsor1 location
NCT04902482
iCycle II: Recovery of Function Through FES Cycling With VR Biofeedback in People With SCI.
NARecruiting
6 participants
Started: Jan 6, 2022 · Completed: Nov 30, 2024
1 condition2 sponsors1 location
NCT06189690
Effect of HF rTMS on Serum BDNF in Cocaine Use Disorder
NARecruiting
102 participants
Started: Jan 6, 2022 · Completed: Dec 1, 2027
1 condition2 sponsors1 location
NCT05023655
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
PHASE2Recruiting
40 participants
Started: Jan 6, 2022 · Completed: Jan 31, 2028
2 conditions2 sponsors1 location
NCT04224974
Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
NARecruiting
266 participants
Started: Jan 6, 2022 · Completed: Dec 31, 2025
1 condition4 sponsors5 locations
NCT05361980
Pediatric Orthopaedic Implant Safety & Efficacy
N/ARecruiting
4,000 participants
Started: Jan 6, 2022 · Completed: Dec 31, 2029
11 conditions2 sponsors1 location
NCT04054401
SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study
NARecruiting
20 participants
Started: Jan 6, 2022 · Completed: Oct 31, 2024
3 conditions1 sponsor2 locations
NCT05152810
Effectiveness of Transcranial Magnetic Stimulation (TMS) in Smoking Cessation, Combining Withdrawal Stimulation Followed by Maintenance Stimulation to Prevent Relapse
NARecruiting
88 participants
Started: Jan 6, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04559230
Sacituzumab Govitecan in Recurrent Glioblastoma
PHASE2Recruiting
32 participants
Started: Jan 6, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor3 locations
NCT05126849
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
PHASE2Recruiting
31 participants
Started: Jan 6, 2022 · Completed: Jan 6, 2027
2 conditions1 sponsor35 locations
NCT05773300
Registry for Mayo Clinic Adult Congenital Heart Disease Control Population
N/ARecruiting
75 participants
Started: Jan 6, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05170958
A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors
PHASE1/PHASE2Recruiting
396 participants
Started: Jan 6, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor49 locations
NCT05035511
A Machine Learning Approach for Predicting TDCS Treatment Outcomes of Adolescents with Autism Spectrum Disorders
NARecruiting
90 participants
Started: Jan 5, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT06116461
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
PHASE4Recruiting
34 participants
Started: Jan 5, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT04757220
Multidimensional Apathy in Psychiatric Pathologies.
NARecruiting
144 participants
Started: Jan 5, 2022 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT05217108
A Mobile Phone Text-based Intervention to Reduce Sedentary Behavior and Engage Communities on the Importance of Healthy Lifestyles: the TEXT2MOVE Study
NARecruiting
200 participants
Started: Jan 5, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor1 location
NCT05099770
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
PHASE3Recruiting
685 participants
Started: Jan 5, 2022 · Completed: Feb 28, 2027
2 conditions1 sponsor80 locations
NCT04840602
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
PHASE2Recruiting
92 participants
Started: Jan 5, 2022 · Completed: Mar 31, 2028
2 conditions1 sponsor113 locations
NCT04449991
Per-protocol Repeat Kidney Biopsy in Incident Cases of Lupus Nephritis
NARecruiting
206 participants
Started: Jan 5, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT05287191
MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care
PHASE3Recruiting
200 participants
Started: Jan 5, 2022 · Completed: Apr 30, 2026
1 condition2 sponsors5 locations
NCT05062252
Mirror Medacta Shoulder System Pivotal Trial
NARecruiting
100 participants
Started: Jan 5, 2022 · Completed: Dec 30, 2027
2 conditions1 sponsor2 locations
NCT05090423
The Effect of Additional Neurodynamic Intervention in Patients With Chronic Ankle Instability
NARecruiting
40 participants
Started: Jan 5, 2022 · Completed: Jul 30, 2024
1 condition1 sponsor1 location
NCT05263479
A Study of HS-20089 in Patients With Advanced Solid Tumors
PHASE1Recruiting
177 participants
Started: Jan 5, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05163951
Trabeculectomy Versus Peripheral Iridectomy Plus Goniotomy in Advanced PACG
NARecruiting
88 participants
Started: Jan 5, 2022 · Completed: Jun 30, 2026
1 condition7 sponsors1 location
NCT05151848
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
PHASE4Recruiting
100 participants
Started: Jan 5, 2022 · Completed: Jan 15, 2026
1 condition1 sponsor4 locations
NCT04892173
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
PHASE3Recruiting
500 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor171 locations
NCT05290337
ZR-CHOP in DLBCL With Specific Gene Abnormality
PHASE2Recruiting
62 participants
Started: Jan 4, 2022 · Completed: Jan 4, 2026
1 condition1 sponsor1 location
NCT05430360
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Jan 4, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05102019
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
NARecruiting
380 participants
Started: Jan 4, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor75 locations
NCT05024162
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
NARecruiting
60 participants
Started: Jan 4, 2022 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05443178
Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
PHASE1Recruiting
16 participants
Started: Jan 4, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT04529434
Star Homes Project 2
NARecruiting
2,750 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05489042
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
NARecruiting
80 participants
Started: Jan 4, 2022 · Completed: Mar 31, 2027
3 conditions3 sponsors1 location
NCT04996628
Pancreatic Quantitative Sensory Testing (P-QST) to Predict Treatment Response for Pain in Chronic Pancreatitis
NARecruiting
150 participants
Started: Jan 4, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors3 locations
NCT05118789
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
PHASE1/PHASE2Recruiting
359 participants
Started: Jan 4, 2022 · Completed: Oct 31, 2026
2 conditions1 sponsor63 locations
NCT05190666
Healthy Living After Knee Replacement
NARecruiting
212 participants
Started: Jan 4, 2022 · Completed: Dec 30, 2026
2 conditions2 sponsors1 location
NCT04969094
Reducing Fall Risk With NMES
NARecruiting
80 participants
Started: Jan 4, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05191706
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
PHASE4Recruiting
60 participants
Started: Jan 4, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor9 locations